Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T83196 Target Info
Target Name PC4 and SFRS1-interacting protein (PSIP1)
Synonyms Transcriptional coactivator p75/p52; PSIP2; Lens epithelium-derived growth factor; LEDGF; Dense fine speckles 70 kDa protein; DFS70; DFS 70; CLL-associated antigen KW-7
Target Type Patented-recorded Target
Gene Name PSIP1
UniProt ID
PSIP1_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US9132129
Title Antiviral compounds
Abstract The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.
Applicant(s) KATHOLIEKE UNIVERSITEIT LEUVEN
Representative Drug(s) D09SDN Drug Info IC50 = 550 nM Click to Show More [1]
2 D0RP0H Drug Info IC50 = 3100 nM [1]
3 D08LBW Drug Info IC50 = 4600 nM [1]
Patent ID US9132129
Title Antiviral compounds
Abstract The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.
Applicant(s) KATHOLIEKE UNIVERSITEIT LEUVEN
Representative Drug(s) D09SDN Drug Info IC50 = 550 nM Click to Show More [1]
2 D0RP0H Drug Info IC50 = 3100 nM [1]
3 D08LBW Drug Info IC50 = 4600 nM [1]
Patent ID US9132129
Title Antiviral compounds
Abstract The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.
Applicant(s) KATHOLIEKE UNIVERSITEIT LEUVEN
Representative Drug(s) D09SDN Drug Info IC50 = 550 nM Click to Show More [1]
2 D0RP0H Drug Info IC50 = 3100 nM [1]
3 D08LBW Drug Info IC50 = 4600 nM [1]
References  Top
REF 1 Antiviral compounds. US9132129.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.